165 related articles for article (PubMed ID: 35524316)
21. Component analysis of a synchronous and asynchronous blended care CBT intervention for symptoms of depression and anxiety: Pragmatic retrospective study.
Lungu A; Wickham RE; Chen SY; Jun JJ; Leykin Y; Chen CE
Internet Interv; 2022 Apr; 28():100536. PubMed ID: 35433277
[TBL] [Abstract][Full Text] [Related]
22. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
[TBL] [Abstract][Full Text] [Related]
23. Improving adherence and clinical outcomes in self-guided internet treatment for anxiety and depression: a 12-month follow-up of a randomised controlled trial.
Titov N; Dear BF; Johnston L; McEvoy PM; Wootton B; Terides MD; Gandy M; Fogliati V; Kayrouz R; Rapee RM
PLoS One; 2014; 9(2):e89591. PubMed ID: 24586897
[TBL] [Abstract][Full Text] [Related]
24. Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.
Ragnhildstveit A; Slayton M; Jackson LK; Brendle M; Ahuja S; Holle W; Moore C; Sollars K; Seli P; Robison R
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326338
[TBL] [Abstract][Full Text] [Related]
25. Use of a Mobile App to Augment Psychotherapy in a Community Psychiatric Clinic: Feasibility and Fidelity Trial.
Adam A; Jain A; Pletnikova A; Bagga R; Vita A; N Richey L; Gould N; Munshaw S; Misrilall K; Peters ME
JMIR Form Res; 2020 Jul; 4(7):e17722. PubMed ID: 32618572
[TBL] [Abstract][Full Text] [Related]
26. Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.
Lipsitz O; Di Vincenzo JD; Rodrigues NB; Cha DS; Lee Y; Greenberg D; Teopiz KM; Ho RC; Cao B; Lin K; Subramaniapillai M; Flint AJ; Kratiuk K; McIntyre RS; Rosenblat JD
Am J Geriatr Psychiatry; 2021 Sep; 29(9):899-913. PubMed ID: 33478865
[TBL] [Abstract][Full Text] [Related]
27. A transdiagnostic community-based mental health treatment for comorbid disorders: development and outcomes of a randomized controlled trial among Burmese refugees in Thailand.
Bolton P; Lee C; Haroz EE; Murray L; Dorsey S; Robinson C; Ugueto AM; Bass J
PLoS Med; 2014 Nov; 11(11):e1001757. PubMed ID: 25386945
[TBL] [Abstract][Full Text] [Related]
28. A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from generalized anxiety disorder with or without comorbidities.
Katzman MA; Vermani M; Gerbarg PL; Brown RP; Iorio C; Davis M; Cameron C; Tsirgielis D
Int J Yoga; 2012 Jan; 5(1):57-65. PubMed ID: 22346068
[TBL] [Abstract][Full Text] [Related]
29. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
Rodrigues NB; McIntyre RS; Lipsitz O; Cha DS; Lee Y; Gill H; Majeed A; Phan L; Nasri F; Ho R; Lin K; Subramaniapillai M; Kratiuk K; Mansur RB; Rosenblat JD
J Affect Disord; 2020 Nov; 276():570-575. PubMed ID: 32871688
[TBL] [Abstract][Full Text] [Related]
30. Affective predictors of the severity and change in eating psychopathology in residential eating disorder treatment: The role of social anxiety.
Smith KE; Mason TB; Leonard RC; Wetterneck CT; Smith BER; Farrell NR; Riemann BC
Eat Disord; 2018; 26(1):66-78. PubMed ID: 29384466
[TBL] [Abstract][Full Text] [Related]
31. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.
Albott CS; Lim KO; Forbes MK; Erbes C; Tye SJ; Grabowski JG; Thuras P; Batres-Y-Carr TM; Wels J; Shiroma PR
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29727073
[TBL] [Abstract][Full Text] [Related]
32. Ketamine and other glutamate receptor modulators for depression in adults.
Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
[TBL] [Abstract][Full Text] [Related]
33. Study Protocol for a randomized controlled trial of mentalization based therapy against specialist supportive clinical management in patients with both eating disorders and symptoms of borderline personality disorder.
Robinson P; Barrett B; Bateman A; Hakeem A; Hellier J; Lemonsky F; Rutterford C; Schmidt U; Fonagy P
BMC Psychiatry; 2014 Feb; 14():51. PubMed ID: 24555511
[TBL] [Abstract][Full Text] [Related]
34. Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.
Drozdz SJ; Goel A; McGarr MW; Katz J; Ritvo P; Mattina GF; Bhat V; Diep C; Ladha KS
J Pain Res; 2022; 15():1691-1706. PubMed ID: 35734507
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS
JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
[TBL] [Abstract][Full Text] [Related]
36. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
37. Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders.
Wisting L; Johnson SU; Bulik CM; Andreassen OA; Rø Ø; Bang L
BMC Psychiatry; 2021 Jan; 21(1):6. PubMed ID: 33402149
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses.
Newman MG; Przeworski A; Fisher AJ; Borkovec TD
Behav Ther; 2010 Mar; 41(1):59-72. PubMed ID: 20171328
[TBL] [Abstract][Full Text] [Related]
39. [Ketamine Augmented Psychotherapy (KAP) in mood disorder: User guide].
Bottemanne H; Baldacci A; Muller C; Boyreau A; Claret A
Encephale; 2022 Jun; 48(3):304-312. PubMed ID: 34876279
[TBL] [Abstract][Full Text] [Related]
40. Differences in eating disorder symptoms and affect regulation for residential eating disorder patients with problematic substance use.
Michael ML; Juarascio A
Eat Weight Disord; 2020 Dec; 25(6):1805-1811. PubMed ID: 31612371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
